Thrombocytopenia overview

Jump to navigation Jump to search

Thrombocytopenia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thrombocytopenia from other Diseases

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thrombocytopenia overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thrombocytopenia overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thrombocytopenia overview

CDC on Thrombocytopenia overview

Thrombocytopenia overview in the news

Blogs on Thrombocytopenia overview

Directions to Hospitals Treating Thrombocytopenia

Risk calculators and risk factors for Thrombocytopenia overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor-In-Chief: Farbod Zahedi Tajrishi, M.D. [2]

Overview

Thrombocytopenia (or -paenia, or thrombopenia in short) is the presence of relatively few platelets in blood.

Generally speaking, a normal platelet count ranges from 150,000 and 450,000 per mm3. These limits, however, are determined by the 2.5th lower and upper percentile, and a deviation does not necessarily imply any form of disease. The number of platelets in a blood sample also decreases quickly with time and a low platelet count may be caused by a delay between sampling and analysis.

Historical Perspective

Classification

Thrombocytopenia can be divided into several categories based on its extent as well as its underlying etiology.

Based on platelet count:

  • mild: (100,000 - 150,000 per µL),
  • moderate (50,000 to 99,000 per µL),
  • severe (<50,000 per µL).

Note that these amounts may not be the same for every condition and one should interpreted them according to the underlying etiology of thrombocytopenia. For example, in idiopathic thrombocytopenia (ITP), a platelet count of <30,000/µL represents severe thrombocytopenia and for gestational thrombocytopenia, a platelet count between 80,000 and 150,000/microL is considered as mild thrombocytopenia.

Based on etiology:

To see the full list of conditions that could cause thrombocytopenia, please click here.

Pathophysiology

Basically, thrombocytopenia is the result of one of these mechanisms or a combination of some of them:

  1. Reduced production of platelets due to bone marrow dysfunction
  2. Increased destruction of platelets in the body
  3. iatrogenic
  4. entrapment of platelets in spleen

Several conditions, some of which mentioned below, can activate the mechanisms that ultimately lead to thrombocytopenia.

Causes

Differentiating [Disease] from Other Diseases

Epidemiology and Demographics

Among people with normal platelet counts:[1][2]

  • The mean platelet count is 266,000/µL in women and 237,000/µL in men.
  • Younger people and those with African-Americans descent have higher platelet counts than the older ones and caucasians, respectively.
  • The variation of the platelet count in a given individual over a certain time course is insignificant.
  • Platelet counts are slightly higher (by approximately 5000/µL) in the fall/winter compared with spring/summer.
  • Almost 2.5 percent of the normal population have platelet counts lower than 150,000/µL.

Risk Factors

Screening

Natural History, Complications, and Prognosis

Natural History

Complications

Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

References

  1. Buckley MF, James JW, Brown DE, Whyte GS, Dean MG, Chesterman CN; et al. (2000). "A novel approach to the assessment of variations in the human platelet count". Thromb Haemost. 83 (3): 480–4. PMID 10744157.
  2. Segal JB, Moliterno AR (2006). "Platelet counts differ by sex, ethnicity, and age in the United States". Ann Epidemiol. 16 (2): 123–30. doi:10.1016/j.annepidem.2005.06.052. PMID 16246584.

Template:WS Template:WH